Research Paper Volume 12, Issue 7 pp 5878—5893

Survival-associated alternative splicing signatures in non-small cell lung cancer

Figure 6. The AS-clinicopathologic nomogram for prediction on survival probability in patients with NSCLC. (AD) Development of AS-clinicopathologic nomogram for predicting 1-, 3-, and 5-years OS for LUAD_MALE group, LUAD_FEMALE group, LUSC_MALE group, and LUSC_FEMALE group, with the final AS signature and independent prognostic factors. (EH) Calibration plot of the AS-clinicopathologic nomogram in terms of agreement between nomogram-predicted and observed 1-, 3-, and 5-years outcomes in four cohorts. The actual performances of our model are shown by green, blue, and red lines. And the silver line of 45° represents the ideal performance.